Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|July 9, 2023
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cellsPradeep Kumar Patnana, Longlong Liu, Daria Frank, et al.
The Lancet. Oncology|August 7, 2025
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trialKim M Pabst, Manuel M Weber, Christina Laschinsky, et al.
Nature Communications|February 6, 2026
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaJuanFei Peng, JiaJin Yang, Georgia Antonopoulou, et al.
Signal Transduction and Targeted Therapy|September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistanceClaire M Storey, Mohamed Altai, Katharina Lückerath, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Cancer Cell|September 15, 2012
EGF receptor is required for KRAS-induced pancreatic tumorigenesisChristine M Ardito, Barbara M Grüner, Kenneth K Takeuchi, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Nature|February 22, 2023
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
Nature Medicine|September 22, 2015
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
Cell Death & Disease|September 29, 2021
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastomaUlvi Ahmadov, Daniel Picard, Jasmin Bartl, et al.
Pageof 6